These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16222566)

  • 1. Backbone 1H, 13C, and 15N resonance assignment of the 46 kDa dimeric GAF A domain of phosphodiesterase 5.
    Sekharan MR; Rajagopal P; Klevit RE
    J Biomol NMR; 2005 Sep; 33(1):75. PubMed ID: 16222566
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Lau DH; Thompson CS; Morgan RJ; Mumtaz FH; Mikhailidis DP
    BJU Int; 2005 Dec; 96(9):1424. PubMed ID: 16287475
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity.
    Matthiesen K; Nielsen J
    Biochem J; 2009 Oct; 423(3):401-9. PubMed ID: 19689430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic nucleotides and phosphodiesterases in platelets.
    Haslam RJ; Dickinson NT; Jang EK
    Thromb Haemost; 1999 Aug; 82(2):412-23. PubMed ID: 10605732
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic hyperammonemia in vivo impairs long-term potentiation in hippocampus by altering activation of cyclic GMP-dependent-protein kinase and of phosphodiesterase 5.
    Monfort P; Muñoz MD; Felipo V
    J Neurochem; 2005 Aug; 94(4):934-42. PubMed ID: 16092938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H, 13C, and 15N NMR assignment of the Rep protein nuclease domain from the porcine circovirus PCV2.
    Rocha SV; Campos-Olivas R
    J Biomol NMR; 2006; 36 Suppl 1():25. PubMed ID: 16636755
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens.
    Seftel AD
    J Urol; 2005 Sep; 174(3):1043. PubMed ID: 16094045
    [No Abstract]   [Full Text] [Related]  

  • 8. Type 5 phosphodiesterase inhibition: the focus shifts to the heart.
    Semigran MJ
    Circulation; 2005 Oct; 112(17):2589-91. PubMed ID: 16246958
    [No Abstract]   [Full Text] [Related]  

  • 9. A chemometric study of phosphodiesterase 5 inhibitors.
    de O Figueiredo LJ; Garrido FM; Kunisawa VY; Aboim CE; Licks OB
    J Mol Graph Model; 2006 Jan; 24(4):227-32. PubMed ID: 16185904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the tandem GAF domain of human phosphodiesterase 5 using a cyanobacterial adenylyl cyclase as a reporter enzyme.
    Bruder S; Schultz A; Schultz JE
    J Biol Chem; 2006 Jul; 281(29):19969-76. PubMed ID: 16690614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors.
    Feixas J; Giovannoni MP; Vergelli C; Gavaldà A; Cesari N; Graziano A; Dal Piaz V
    Bioorg Med Chem Lett; 2005 May; 15(9):2381-4. PubMed ID: 15837329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H, 13C and 15N backbone assignment and secondary structure of the 19 kDa diadenosine 5', 5'''-P1, P4-tetraphosphate hydrolase from Lupinus angustifolius L.
    Swarbrick JD; Bashtannyk T; Maksel D; Pau RN; Gayler KR; Gooley PR
    J Biomol NMR; 2000 Mar; 16(3):269-70. PubMed ID: 10805134
    [No Abstract]   [Full Text] [Related]  

  • 13. Confirmation of tyrosine 698 in beta subunit of cGMP phosphodiesterase in patients with retinitis pigmentosa and population of the west of Mexico.
    Núñez-Gutiérrez IC; García-Cruz D; Fragoso-Herrera R; Medina-Lozano C
    Rev Invest Clin; 2006; 58(4):359-61. PubMed ID: 17146947
    [No Abstract]   [Full Text] [Related]  

  • 14. Assignment of the 1H, 13C and 15N resonances of the catalytic domain of the rat 2',3'-cyclic nucleotide 3'-phosphodiesterase.
    Kozlov G; Lee J; Gravel M; Ekiel I; Braun PE; Gehring K
    J Biomol NMR; 2002 Jan; 22(1):99-100. PubMed ID: 11885989
    [No Abstract]   [Full Text] [Related]  

  • 15. [7 years PDE-5 inhibitor for therapy of erection disorders].
    Krankenpfl J; 2005; 43(7-10):267. PubMed ID: 16518894
    [No Abstract]   [Full Text] [Related]  

  • 16. Interruption of homologous desensitization in cyclic guanosine 3',5'-monophosphate signaling restores colon cancer cytostasis by bacterial enterotoxins.
    Pitari GM; Baksh RI; Harris DM; Li P; Kazerounian S; Waldman SA
    Cancer Res; 2005 Dec; 65(23):11129-35. PubMed ID: 16322263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A solid-phase approach towards the synthesis of PDE5 inhibitors.
    Beer D; Bhalay G; Dunstan A; Glen A; Haberthuer S; Moser H
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1973-6. PubMed ID: 12113821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the GAF domain, a ubiquitous signaling motif and a new class of cyclic GMP receptor.
    Ho YS; Burden LM; Hurley JH
    EMBO J; 2000 Oct; 19(20):5288-99. PubMed ID: 11032796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J; Markerink-van Ittersum M; Vles JS
    J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1H, 13C, and 15N chemical shift assignments for the N-terminal extracellular domain of T-cadherin.
    Bang E; Häussinger D; Stetefeld J; Ahrens T; Grzesiek S; Dames SA
    J Biomol NMR; 2007 Jun; 38(2):179. PubMed ID: 17180550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.